0001209191-21-052744.txt : 20210820
0001209191-21-052744.hdr.sgml : 20210820
20210820160241
ACCESSION NUMBER: 0001209191-21-052744
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210819
FILED AS OF DATE: 20210820
DATE AS OF CHANGE: 20210820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wolchko J Scott
CENTRAL INDEX KEY: 0001586893
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36076
FILM NUMBER: 211193818
MAIL ADDRESS:
STREET 1: C/O FATE THERAPEUTICS, INC.
STREET 2: 3535 GENERAL ATOMICS COURT, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FATE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001434316
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 651311552
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
BUSINESS PHONE: 858.875.1803
MAIL ADDRESS:
STREET 1: 12278 SCRIPPS SUMMIT DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-19
0
0001434316
FATE THERAPEUTICS INC
FATE
0001586893
Wolchko J Scott
C/O FATE THERAPEUTICS, INC.;
12278 SCRIPPS SUMMIT DRIVE
SAN DIEGO
CA
92131
1
1
0
0
President and CEO
Common Stock
2021-08-19
4
M
0
20000
4.835
A
413793
D
Common Stock
2021-08-19
4
S
0
20000
88.0102
D
393793
D
Stock Option (Right to Buy)
4.835
2021-08-19
4
M
0
20000
0.00
D
2025-01-04
Common Stock
20000
4846
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020.
This option is fully vested.
/s/ Cindy Tahl, Attorney-in-Fact
2021-08-20